Spire Healthcare Group plc

("Spire Healthcare", "the Company" or "the Group")

Notice of Capital Markets Day

6 May 2022

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, will be holding a Capital Markets Day for investors, analysts and lending banks at 10:15am BST on Wednesday 29 June 2022.

The event will be led by CEO Justin Ash and include a series of presentations by senior executives to provide a detailed overview of the Company's evolving strategy.

The Capital Markets Day will be held at Spire Healthcare's offices, 3 Dorset Rise, London EC4Y 8EN, and is expected to last from 10:15am - 1:00pm BST. Refreshments and a light lunch will be provided.

There will also be a virtual option for those who cannot attend in-person.

To register for the event, please email spire@instinctif.com.

- Ends -

For further information please contact:

Registered Office and Head Office:

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

About Spire Healthcare

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and eight clinics across England, Wales and Scotland.

Working in partnership with around 8,150 experienced Consultants, Spire Healthcare delivered tailored, personalised care to almost 870,000 in-patients and daycase patients in 2021, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 95% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.